These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10789338)

  • 21. Clinical issues associated with maintenance treatment of patients with schizophrenia.
    Guthrie SK
    Am J Health Syst Pharm; 2002 Sep; 59(17 Suppl 5):S19-24. PubMed ID: 12227083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of schizophrenia with "atypical antipsychotic drugs". Quality of life as a measure of treatment success].
    Krankenpfl J; 2002; 40(7-9):230-1. PubMed ID: 12514869
    [No Abstract]   [Full Text] [Related]  

  • 23. The influence of adherence to antipsychotics medication on the quality of life among patients with schizophrenia in Indonesia.
    Endriyani L; Chien CH; Huang XY; Chieh-Yu L
    Perspect Psychiatr Care; 2019 Apr; 55(2):147-152. PubMed ID: 29578605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of life and its association with insight, adverse effects of medication and use of atypical antipsychotics in patients with bipolar disorder and schizophrenia in remission.
    Yen CF; Cheng CP; Huang CF; Yen JY; Ko CH; Chen CS
    Bipolar Disord; 2008 Jul; 10(5):617-24. PubMed ID: 18657246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of life in the long-term treatment and the role of second-generation antipsychotics.
    Mohr P
    Neuro Endocrinol Lett; 2007 Feb; 28 Suppl 1():117-33. PubMed ID: 17262004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gender differences in response to antipsychotic treatment in outpatients with schizophrenia.
    Usall J; Suarez D; Haro JM;
    Psychiatry Res; 2007 Dec; 153(3):225-31. PubMed ID: 17681611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Symptom domains of schizophrenia: the role of atypical antipsychotic agents.
    Burton S
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):6-19. PubMed ID: 17046984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacotherapy of schizophrenia: ploypharmacy approaches.
    Rahiminejad F; Akhondzadeh S
    Acta Med Iran; 2010; 48(4):203-8. PubMed ID: 21279929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluphenazine (oral) versus atypical antipsychotics for schizophrenia.
    Sampford JR; Sampson S; Li BG; Zhao S; Xia J; Furtado VA
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD010832. PubMed ID: 27370402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of novel and conventional antipsychotic medication on subjective quality of life.
    Tempier R; Pawliuk N
    J Psychiatry Neurosci; 2001 Mar; 26(2):131-6. PubMed ID: 11291530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antipsychotic medication, functional outcome and quality of life in schizophrenia: focus on amisulpride.
    Nuss P; Tessier C
    Curr Med Res Opin; 2010 Apr; 26(4):787-801. PubMed ID: 20121655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of weight gain on quality of life among persons with schizophrenia.
    Allison DB; Mackell JA; McDonnell DD
    Psychiatr Serv; 2003 Apr; 54(4):565-7. PubMed ID: 12663847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antipsychotic polypharmacy and quality of life in patients with schizophrenia treated in primary care in China.
    Hou CL; Ma XR; Zang Y; Jia FJ; Lin YQ; Chiu HF; Ungvari GS; Ng CH; Zhong BL; Cao XL; Li Y; Cai MY; Xiang YT
    Int J Clin Pharmacol Ther; 2016 Jan; 54(1):36-42. PubMed ID: 26521927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Functionality as a goal in the treatment of schizophrenia].
    García B;
    Actas Esp Psiquiatr; 2002; 30(5):312-25. PubMed ID: 12372228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of life and new antipsychotics in schizophrenia. Are patients better off?
    Awad AG; Voruganti LN
    Int J Soc Psychiatry; 1999; 45(4):268-75. PubMed ID: 10689610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quetiapine versus typical antipsychotic medications for schizophrenia.
    Suttajit S; Srisurapanont M; Xia J; Suttajit S; Maneeton B; Maneeton N
    Cochrane Database Syst Rev; 2013 May; (5):CD007815. PubMed ID: 23728667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sertindole, a new atypical antipsychotic for the treatment of schizophrenia.
    Brown LA; Levin GM
    Pharmacotherapy; 1998; 18(1):69-83. PubMed ID: 9469684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical antipsychotic drugs: current issues of safety and efficacy in the management of schizophrenia.
    Vohora D
    Curr Opin Investig Drugs; 2007 Jul; 8(7):531-8. PubMed ID: 17659473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-acting risperidone and oral antipsychotics in unstable schizophrenia.
    Rosenheck RA; Krystal JH; Lew R; Barnett PG; Fiore L; Valley D; Thwin SS; Vertrees JE; Liang MH;
    N Engl J Med; 2011 Mar; 364(9):842-51. PubMed ID: 21366475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Non-Interventional Naturalistic Study of the Prescription Patterns of Antipsychotics in Patients with Schizophrenia from the Spanish Province of Tarragona.
    Gaviria AM; Franco JG; Aguado V; Rico G; Labad J; de Pablo J; Vilella E
    PLoS One; 2015; 10(10):e0139403. PubMed ID: 26427051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.